Clinical trials of cis-diamminedichloroplatinum (NSC-119875).
D058186:Acute Kidney Injury / Q000139:chemically induced; D000328:Adult; D000368:Aged; D001761:Bleomycin / Q000627:therapeutic use; D001806:Blood Urea Nitrogen; D001842:Bone and Bones / Q000187:drug effects; D002945:Cisplatin / Q000008:administration & dosage / Q000009:adverse effects / Q000494:pharmacology / Q000627:therapeutic use*; D003404:Creatinine / Q000378:metabolism; D004305:Dose-Response Relationship, Drug; D005260:Female; D006311:Hearing Disorders / Q000139:chemically induced; D006320:Hearing Tests; D006801:Humans; D007668:Kidney / Q000502:physiology; D007938:Leukemia / Q000188:drug therapy; D007970:Leukopenia / Q000139:chemically induced; D008297:Male; D008875:Middle Aged; D009325:Nausea / Q000139:chemically induced; D009369:Neoplasms / Q000097:blood / Q000188:drug therapy*; D014839:Vomiting / Q000139:chemically induced
D001761:Bleomycin; D003404:Creatinine; D002945:Cisplatin